Jefferies Financial Group Inc. Cuts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Jefferies Financial Group Inc. decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,944 shares of the medical equipment provider’s stock after selling 425 shares during the period. Jefferies Financial Group Inc.’s holdings in Intuitive Surgical were worth $2,581,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Bernard Wealth Management Corp. acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $56,000. Capital A Wealth Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $1,045,000. Financial Advisory Corp purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $258,000. Integrated Advisors Network LLC grew its holdings in Intuitive Surgical by 14.0% during the 4th quarter. Integrated Advisors Network LLC now owns 1,998 shares of the medical equipment provider’s stock valued at $1,043,000 after purchasing an additional 245 shares in the last quarter. Finally, Hall Capital Management Co. Inc. purchased a new stake in Intuitive Surgical during the 4th quarter worth $240,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $550.19 on Wednesday. The firm has a fifty day moving average of $513.67 and a 200-day moving average of $538.20. The company has a market cap of $197.20 billion, a price-to-earnings ratio of 85.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1 year low of $396.15 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the previous year, the business posted $1.50 EPS. Analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Barclays decreased their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Royal Bank of Canada reduced their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. Evercore ISI reduced their target price on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research note on Wednesday, April 23rd. Finally, Piper Sandler dropped their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a research report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $596.05.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 188 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the transaction, the chief financial officer now owns 7,162 shares of the company’s stock, valued at approximately $4,060,424.28. This represents a 2.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 32,700 shares of company stock valued at $16,865,621 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.